Cerebrolysin, what the science actually shows

Cerebrolysin is a porcine-brain-derived peptide preparation studied for stroke recovery and cognitive decline. Approved in Europe and Asia; not FDA-approved in the US. Evidence base: RCT data for stroke and dementia; limited for healthy cognitive enhancement.

A standardized mixture of neuropeptides and amino acids from porcine brain. Used in 40+ countries for stroke recovery, TBI, and neurodegeneration. Not FDA-approved but with substantial international clinical data.

Evidence
★★★☆☆ Moderate
Type
Peptide Mixture
Structure
Peptide + amino acid mixture

What Cerebrolysin is

Proprietary peptide preparation by Ever Pharma (Austria) since the 1970s. Standardized enzymatic breakdown of porcine brain proteins: ~25% low-MW peptides and ~75% free amino acids. Peptide fraction mimics BDNF, GDNF, NGF, and CNTF activity. Administered IM or IV.

Mechanism, in plain English

Peptide components mimic neurotrophic factors. Activate PI3K/Akt and MAPK/ERK cascades promoting neuronal survival, synaptic plasticity, and neurogenesis. Inhibit calpain-mediated damage, reduce excitotoxicity, and have anti-inflammatory neural effects.

Want all cognitive compounds in one place?

Get the Cognitive Enhancement Guide →

What the evidence shows

Stroke: multiple RCTs show improved motor and cognitive recovery. CASTA trial (1,070 patients) showed improved 90-day outcomes. Alzheimer's: modest cognitive improvement in several RCTs. TBI: improved Glasgow Outcome scores. Criticism: many positive trials industry-funded, from countries without FDA-level scrutiny.

FDA status

Not FDA-approved. Available in 40+ countries including Austria, Germany, Russia, China.

Common synonyms

Cerebrolysin, FPF 1070

Safety and adverse-event landscape

Well-tolerated with millions of patient-exposures. Injection site reactions, dizziness, headache. Theoretical prion risk from animal tissue (no cases reported).

Frequently asked questions

FDA requires specific US-based trial designs. Cerebrolysin's evidence is primarily international.
Cerebrolysin is complex biological mixture, injected. Noopept is single synthetic compound, oral. Cerebrolysin has more clinical data but requires injection.
Modest improvements in Alzheimer's cognitive scores. Whether it slows disease progression is not established.
No. Peptexa is educational only.

Related on Peptexa

Noopept, synthetic nootropic Semax. ACTH-derived nootropic All cognitive compounds Take the peptide quiz

The full Cognitive Enhancement reference

Mechanism, evidence level, and FDA status for every compound.

Get the Cognitive Enhancement Guide →